Active Recombinant Human CADM2

• Cat.No.: CADM2-357H
• Product Overview: Recombinant Human CADM2 (Accession # AAI06000) was produced in Mouse myeloma cell line, NS0-derived.

Specification

• Species: Human
• Source: Mammalian Cells
• Tag: Non
• Predicted N Terminal: Ala21
• Form: Lyophilized from a 0.2 µm filtered solution in PBS.
• Bio-activity: Measured by its ability to enhance neurite outgrowth of E16-E18 rat embryonic cortical neurons.Able to significantly enhance neurite outgrowth when immobilized as a 3 µL droplet containing 50 ng on a nitrocellulose-coated microplate.
• Molecular Mass: Recombinant Human CADM2 has a calculated MW of 35.5 kDa (monomer). In SDS-PAGE migrates as 36-55 kDa, reducing conditions.
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).

Gene Information

• Gene Name: CADM2 cell adhesion molecule 2 [ Homo sapiens ]
• Official Symbol: CADM2
• Synonyms: CADM2; cell adhesion molecule 2; IGSF4D, immunoglobulin superfamily, member 4D; Necl 3; NECL3; nectin like 3; SynCAM2; nectin-like 3; nectin-like protein 3; immunoglobulin superfamily member 4D; immunoglobulin superfamily, member 4D; IGSF4D; Necl-3; synCAM2; MGC104534; MGC138341; MGC138343
• Gene ID: 253559
• mRNA Refseq: NM_001167674
• Protein Refseq: NP_001161146
• MIM: 609938
• UniProt ID: Q8N3J6
• Chromosome Location: 3p12.2